
Thursday, September 03, 2020 7:34:54 AM

Liked By
Spread the love. Be the first to like this post!
Recent AMRN News
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 02/02/2023 10:22:19 PM
- Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership • GlobeNewswire Inc. • 02/02/2023 09:30:00 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 02/01/2023 09:31:33 PM
- Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders • Business Wire • 02/01/2023 09:09:00 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/31/2023 10:29:44 PM
- Proxy Statment - Contested Solicitations (definitive) (defc14a) • Edgar (US Regulatory) • 01/31/2023 10:27:40 PM
- Proxy Soliciting Materials (revised) (prrn14a) • Edgar (US Regulatory) • 01/31/2023 09:13:39 PM
- Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders • GlobeNewswire Inc. • 01/31/2023 01:24:38 PM
- ADRs End Lower; Amarin, ArcelorMittal Trade Actively • Dow Jones News • 01/27/2023 10:48:00 PM
- Proxy Soliciting Materials (revised) (prrn14a) • Edgar (US Regulatory) • 01/27/2023 09:36:24 PM
- Proxy Soliciting Materials (revised) (prer14a) • Edgar (US Regulatory) • 01/27/2023 09:09:58 PM
- Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand • GlobeNewswire Inc. • 01/27/2023 01:45:00 PM
- Proxy Soliciting Materials (revised) (prer14a) • Edgar (US Regulatory) • 01/27/2023 01:03:05 PM
- Amarin to Present at SVB Securities Global Biopharma Conference • GlobeNewswire Inc. • 01/27/2023 01:00:00 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/23/2023 10:16:57 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/19/2023 09:07:08 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 01/19/2023 09:01:47 PM
- Proxy Statement - Contested Solicitations (preliminary) (prec14a) • Edgar (US Regulatory) • 01/19/2023 01:43:40 PM
- Amarin Responds to Inaccurate and Misleading Statement by Sarissa • GlobeNewswire Inc. • 01/19/2023 12:00:00 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 01/18/2023 10:25:11 PM
- Sarissa Capital Calls Out Amarin’s Sham Board Refreshment • Business Wire • 01/18/2023 12:30:00 PM
- Proxy Statement - Contested Solicitations (preliminary) (prec14a) • Edgar (US Regulatory) • 01/17/2023 01:08:33 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/12/2023 02:29:40 PM
- Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders • GlobeNewswire Inc. • 01/11/2023 09:33:31 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 01/11/2023 11:02:38 AM
FEATURED Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • Feb 2, 2023 9:58 AM
FEATURED Hempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products • Feb 2, 2023 9:30 AM
FEATURED American Green (OTC:ERBB) Receives Equipment Lease Funding for its 40K s.f. Cypress Chill Cannabis Grow • Feb 2, 2023 7:03 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Kona Gold Beverage, Inc Announces Record Revenue Month in January Eclipsing Half a Million Dollars for the First Time • KGKG • Feb 2, 2023 9:00 AM
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm • BLFE • Feb 2, 2023 8:32 AM